Lisa Delfini
Insider
First SEC filing: May 24, 2024 · Latest: May 24, 2024
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 31, 2025 | TRVI | A | 72,000 | · | · | 110,400 Direct | +187.50% | Acquired | (price as of 2026-10-05) |
| March 10, 2025 | TRVI | A | 38,400 | · | · | 38,400 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 18, 2025 | TRVI | A | 225,500 | · | · | 225,500 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 8, 2025 | TRVI | M | 5,000 | · | · | 42,125 Direct | -10.61% | Disposed | (price as of 2026-10-05) |
| Jan. 8, 2025 | TRVI | M | 5,000 | $0.51 | $2,550 | 64,660 Direct | +8.38% | Acquired | 2590.2% (price as of 2026-10-05) |
| Jan. 7, 2025 | TRVI | M | 1,000 | · | · | 47,125 Direct | -2.08% | Disposed | (price as of 2026-10-05) |
| Jan. 7, 2025 | TRVI | M | 1,000 | $0.51 | $510 | 59,660 Direct | +1.70% | Acquired | 2590.2% (price as of 2026-10-05) |
| May 22, 2024 | TRVI | M | 16,043 | · | · | 48,125 Direct | -25.00% | Disposed | (price as of 2026-10-05) |
| May 22, 2024 | TRVI | S | 4,350 | $2.64 | $11,484 | 53,279 Direct | -7.55% | Disposed | 419.7% (price as of 2026-10-05) |
| May 22, 2024 | TRVI | M | 16,043 | $0.51 | $8,182 | 57,629 Direct | +38.58% | Acquired | 2590.2% (price as of 2026-10-05) |
| Feb. 15, 2024 | TRVI | A | 175,000 | · | · | 175,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 11, 2023 | TRVI | M 10b5-1 | 2,292 | · | · | 64,168 Direct | -3.45% | Disposed | (price as of 2026-10-05) |
| Oct. 11, 2023 | TRVI | S | 785 | $2.02 | $1,586 | 35,901 Direct | -2.14% | Disposed | 579.2% (price as of 2026-10-05) |
| Oct. 11, 2023 | TRVI | M 10b5-1 | 2,292 | $0.51 | $1,169 | 36,686 Direct | +6.66% | Acquired | 2590.2% (price as of 2026-10-05) |
| Sept. 11, 2023 | TRVI | M 10b5-1 | 2,291 | · | · | 66,460 Direct | -3.33% | Disposed | (price as of 2026-10-05) |
| Sept. 11, 2023 | TRVI | S | 711 | $2.20 | $1,564 | 34,394 Direct | -2.03% | Disposed | 523.6% (price as of 2026-10-05) |
| Sept. 11, 2023 | TRVI | M 10b5-1 | 2,291 | $0.51 | $1,168 | 35,105 Direct | +6.98% | Acquired | 2590.2% (price as of 2026-10-05) |
| Aug. 11, 2023 | TRVI | M 10b5-1 | 2,292 | · | · | 68,751 Direct | -3.23% | Disposed | (price as of 2026-10-05) |
| Aug. 11, 2023 | TRVI | S | 682 | $2.36 | $1,610 | 32,814 Direct | -2.04% | Disposed | 481.4% (price as of 2026-10-05) |
| Aug. 11, 2023 | TRVI | M 10b5-1 | 2,292 | $0.51 | $1,169 | 33,496 Direct | +7.35% | Acquired | 2590.2% (price as of 2026-10-05) |
| July 11, 2023 | TRVI | M 10b5-1 | 2,292 | · | · | 71,043 Direct | -3.13% | Disposed | (price as of 2026-10-05) |
| July 11, 2023 | TRVI | S | 687 | $2.34 | $1,608 | 31,204 Direct | -2.15% | Disposed | 486.3% (price as of 2026-10-05) |
| July 11, 2023 | TRVI | M 10b5-1 | 2,292 | $0.51 | $1,169 | 31,891 Direct | +7.74% | Acquired | 2590.2% (price as of 2026-10-05) |
| June 12, 2023 | TRVI | M 10b5-1 | 2,291 | · | · | 73,335 Direct | -3.03% | Disposed | (price as of 2026-10-05) |
| June 12, 2023 | TRVI | S | 610 | $2.64 | $1,610 | 29,599 Direct | -2.02% | Disposed | 419.7% (price as of 2026-10-05) |
| June 12, 2023 | TRVI | M 10b5-1 | 2,291 | $0.51 | $1,168 | 30,209 Direct | +8.21% | Acquired | 2590.2% (price as of 2026-10-05) |
| May 11, 2023 | TRVI | M 10b5-1 | 2,291 | · | · | 75,626 Direct | -2.94% | Disposed | (price as of 2026-10-05) |
| May 11, 2023 | TRVI | S | 562 | $2.89 | $1,624 | 27,918 Direct | -1.97% | Disposed | 374.7% (price as of 2026-10-05) |
| May 11, 2023 | TRVI | M 10b5-1 | 2,291 | $0.51 | $1,168 | 28,480 Direct | +8.75% | Acquired | 2590.2% (price as of 2026-10-05) |
| April 11, 2023 | TRVI | M 10b5-1 | 2,292 | · | · | 77,917 Direct | -2.86% | Disposed | (price as of 2026-10-05) |
| April 11, 2023 | TRVI | S | 840 | $1.84 | $1,546 | 26,189 Direct | -3.11% | Disposed | 645.7% (price as of 2026-10-05) |
| April 11, 2023 | TRVI | M 10b5-1 | 2,292 | $0.51 | $1,169 | 27,029 Direct | +9.27% | Acquired | 2590.2% (price as of 2026-10-05) |
| March 13, 2023 | TRVI | M 10b5-1 | 2,291 | · | · | 80,209 Direct | -2.78% | Disposed | (price as of 2026-10-05) |
| March 13, 2023 | TRVI | S | 892 | $1.75 | $1,561 | 24,737 Direct | -3.48% | Disposed | 684.0% (price as of 2026-10-05) |
| March 13, 2023 | TRVI | M 10b5-1 | 2,291 | $0.51 | $1,168 | 25,629 Direct | +9.82% | Acquired | 2590.2% (price as of 2026-10-05) |
| Feb. 16, 2023 | TRVI | A | 187,500 | · | · | 187,500 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 13, 2023 | TRVI | M | 27,500 | · | · | 82,500 Direct | -25.00% | Disposed | (price as of 2026-10-05) |
| Feb. 13, 2023 | TRVI | S | 8,474 | $2.45 | $20,761 | 23,338 Direct | -26.64% | Disposed | 460.0% (price as of 2026-10-05) |
| Feb. 13, 2023 | TRVI | M 10b5-1 | 27,500 | $0.51 | $14,025 | 31,812 Direct | +637.76% | Acquired | 2590.2% (price as of 2026-10-05) |
| Feb. 11, 2022 | TRVI | A | 110,000 | · | · | 110,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 9, 2021 | TRVI | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 31, 2025 | TRVI | Performance Stock Option (right to buy) | Common Stock | $2.38 | Feb. 14, 2034 | 72,000 | Acquired |
| March 10, 2025 | TRVI | Performance Stock Option (right to buy) | Common Stock | $2.38 | Feb. 14, 2034 | 38,400 | Acquired |
| Feb. 18, 2025 | TRVI | Stock Option (right to buy) | Common Stock | $4.22 | Feb. 17, 2035 | 225,500 | Acquired |
| Jan. 8, 2025 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 5,000 | Disposed |
| Jan. 7, 2025 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 1,000 | Disposed |
| May 22, 2024 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 16,043 | Disposed |
| Feb. 15, 2024 | TRVI | Stock Option (right to buy) | Common Stock | $2.38 | Feb. 14, 2034 | 175,000 | Acquired |
| Oct. 11, 2023 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 2,292 | Disposed |
| Sept. 11, 2023 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 2,291 | Disposed |
| Aug. 11, 2023 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 2,292 | Disposed |
| July 11, 2023 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 2,292 | Disposed |
| June 12, 2023 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 2,291 | Disposed |
| May 11, 2023 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 2,291 | Disposed |
| April 11, 2023 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 2,292 | Disposed |
| March 13, 2023 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 2,291 | Disposed |
| Feb. 16, 2023 | TRVI | Stock Option (right to buy) | Common Stock | $2.67 | Feb. 15, 2033 | 187,500 | Acquired |
| Feb. 13, 2023 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 27,500 | Disposed |
| Feb. 11, 2022 | TRVI | Stock Option (right to buy) | Common Stock | $0.51 | Feb. 10, 2032 | 110,000 | Acquired |
| Aug. 9, 2021 | TRVI | Stock Option (right to buy) | Common Stock | $1.97 | Aug. 8, 2031 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $412,169 | $182,160 | · | · | · | · | $10,350 | $1,187,403 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.